Impact of genetic abnormalities after allogeneic stem cell transplantation in multiple myeloma: report of the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC)

Background and aim: Del (13q), t (4;14) and del (17p) are wellrecognized poor prognostic genetic abnormalities in multiple myeloma after standard chemotherapy and autologous stem cell transplantation (SCT). We investigated the impact of these genetic abnormalities, detected by fluorescence in situ h...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2009-03, Vol.43 (S1), p.S18
Hauptverfasser:	Roos Weil, D, Moreau, P, Avet-Loiseau, H, Kuentz, M, Milpied, N, Socie, G, Furst, S, Huynh, A, Vigouroux, S, Le Gouill, S, Thiebault, A, Buzyn, A, Cahn, J.-Y, Maillard, N, Yakoub-Agha, I, Soulier, J, Raus, N, Fernand, J.-P, Rio, B, Golmard, J.L, Attal, M, Blaise, D, Michallet, M, Dhedin, N
Format:	Artikel
Sprache:	eng
Schlagworte:	Care and treatment Genetic aspects Genetic disorders Multiple myeloma Prognosis Risk factors Stem cells Transplantation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!